U.S. Patent Office Approves World's First Heat-Stable Rotavirus Vaccine, an Industrial Info Market Brief
U.S. Patent Office Approves World's First Heat-Stable Rotavirus Vaccine, an Industrial Info Market Brief
Attachment: India pharma plants 0819
The United States Patent and Trademark Office (USPTO) has granted approval to Rotasiil, the world's first heat-stable rotavirus vaccine. It was developed by Serum Institute of India, which produces and sells more doses globally than any other vaccine manufacturer, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021